Significant Differences in Stem Cell Transplant Utilization Rates (STUR) of Autologous Hematopoietic Cell Transplant (AHCT) in Multiple Myeloma (MM) Based on Ethnicity without Differences in Efficacy. a CIBMTR Report

Schriber Jeffrey R.; Hari Parmeswaran; Ahn Kwang Woo; Fei Mingwei; Krishnan Amrita; DSouza Anita

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Significant Differences in Stem Cell Transplant Utilization Rates (STUR) of Autologous Hematopoietic Cell Transplant (AHCT) in Multiple Myeloma (MM) Based on Ethnicity without Differences in Efficacy. a CIBMTR Report

【24h】

Significant Differences in Stem Cell Transplant Utilization Rates (STUR) of Autologous Hematopoietic Cell Transplant (AHCT) in Multiple Myeloma (MM) Based on Ethnicity without Differences in Efficacy. a CIBMTR Report

机译：基于种族无功效差异的多发性骨髓瘤（MM）中自体造血细胞移植（AHCT）的干细胞移植利用率（STUR）的显着差异。 CIBMTR报告

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology 》 |2016年第22期| 共5页
作者
Schriber Jeffrey R.; Hari Parmeswaran; Ahn Kwang Woo; Fei Mingwei; Krishnan Amrita; DSouza Anita;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Significant Differences in Stem Cell Transplant Utilization Rates (STUR) of Autologous Hematopoietic Cell Transplant (AHCT) in Multiple Myeloma (MM) Based on Ethnicity without Differences in Efficacy. a CIBMTR Report [J] . Schriber Jeffrey R., Hari Parmeswaran, Ahn Kwang Woo, Blood: The Journal of the American Society of Hematology . 2016 ,第22期

机译：基于种族无功效差异的多发性骨髓瘤（MM）中自体造血细胞移植（AHCT）的干细胞移植利用率（STUR）的显着差异。 CIBMTR报告
2. Hispanics Have the Lowest Stem Cell Transplant Utilization Rate for Autologous Hematopoietic Cell Transplantation for Multiple Myeloma in the United States: A CIBMTR Report [J] . Schriber Jeffrey R., Hari Parameswaran N., Ahn Kwang Woo, Cancer: A Journal of the American Cancer Society . 2017 ,第16期

机译：西班牙裔人具有最低的干细胞移植利用率，用于美国多发性骨髓瘤的自体造血细胞移植：CIBMTR报告
3. Patients (pts) with Renal Insufficiency (RI) and Multiple Myeloma (MM) Have Similar Outcomes after Autologous Hematopoietic Cell Transplantation (AHCT) As Those without [J] . Mahindra Anuj, Hari Parmeswaran, Fraser Raphael, Blood: The Journal of the American Society of Hematology . 2016 ,第22期

机译：患者（PTS）具有肾功能不全（RI）和多发性骨髓瘤（MM）在自体造血细胞移植（AHCT）之后具有类似的结果作为没有
4. NK cells, T-Iymphocyte subsets, and serum cytoklnes six months after autologous hematopoietic stem cell transplantation [C] . Nikolova M., Michova A., Gartcheva L., European Congress of Immunology . 2009

机译：NK细胞，T-inymphyte子集和自体造血干细胞移植后六个月六个月血清Cytoklnes
5. Strategies to Improve Outcomes in Multiple Myeloma: Preclinical Therapeutics Targeting MEK, HDAC and BCL-2 and Optimizing Autologous Hematopoietic Cell Transplantation [D] . Miller, Kevin Charles. 2020

机译：改善多发性骨髓瘤结果的策略：靶向MEK，HDAC和BCL-2的临床前治疗方法以及优化自体造血细胞移植
6. Hispanics have the Lowest Stem Cell Utilization Rate for Autologous Hematopoietic Cell Transplantation for Multiple Myeloma in the United States: a CIBMTR Report [O] . Jeffrey R Schriber, Parameswaran N Hari, Kwang Woo Ahn, -1

机译：西班牙裔美国人在美国多发性骨髓瘤的自体造血细胞移植中具有最低的干细胞利用率：CIBMTR报告
7. Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report [O] . Jeffrey R. Schriber, Parameswaran N. Hari, Kwang Woo Ahn, 2017

机译：西班牙裔美国西班牙裔人具有最低的茎细胞移植利用率，用于美国多发性骨髓瘤的自体造血细胞移植：CIBMTR报告

Significant Differences in Stem Cell Transplant Utilization Rates (STUR) of Autologous Hematopoietic Cell Transplant (AHCT) in Multiple Myeloma (MM) Based on Ethnicity without Differences in Efficacy. a CIBMTR Report

著录项

相似文献

相关主题

期刊订阅